Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-002489

MELINTA THERAPEUTICS, INC. /NEW/ · MLNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 9:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———15,392D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F6$3.00Jan 3, 2017A15,000A—Jan 2, 2027Common Stock15,00015,000D
Stock Option (Right to Buy)F2,F1$7.62holding————Mar 19, 2022Common Stock15,00015,000D
Stock Option (Right to Buy)F2,F3$6.79holding————Feb 3, 2023Common Stock15,00015,000D
Stock Option (Right to Buy)F4$23.51holding————Dec 31, 2024Common Stock15,00015,000D
Stock Option (Right to Buy)F5$31.13holding————Dec 31, 2025Common Stock15,00015,000D

Explanation of responses